Progressive increase in community-associated methicillin-resistant Staphylococcus aureus in Indigenous populations in northern Australia from 1993 to 2012

Epidemiology and Infection

Volumn 143, Issue 7, 2015, Pages 1519-1523

  Tong, S Y C ^a   Varrone, L ^a   Chatfield, M D ^a   Beaman, M ^b   Giffard, P M ^a  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Antibiotic resistance; community epidemics; methicillin resistant S. aureus (MRSA); trimethoprim sulfamethoxazole

Indexed keywords

AZITHROMYCIN; CEFALEXIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; FLUCLOXACILLIN; MACROLIDE; METICILLIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRALIA; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; COMMUNITY ACQUIRED INFECTION; HUMAN; INCIDENCE; INDIGENOUS PEOPLE; INFECTION SENSITIVITY; LONGITUDINAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; SEX DIFFERENCE; ADOLESCENT; ADULT; AGED; CHILD; COMMUNITY-ACQUIRED INFECTIONS; DRUG EFFECTS; INFANT; ISOLATION AND PURIFICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; NEWBORN; OCEANIC ANCESTRY GROUP; PENICILLIN RESISTANCE; PHYSIOLOGY; PRESCHOOL CHILD; STAPHYLOCOCCAL INFECTIONS; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INFANT; INFANT, NEWBORN; MACROLIDES; METHICILLIN; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NORTHERN TERRITORY; OCEANIC ANCESTRY GROUP; STAPHYLOCOCCAL INFECTIONS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 84926408737     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268814002611     Document Type: Article

References (14)

1. World Health Organization. Antimicrobial resistance: global report on surveillance (http://www.who.int/drugresistance/documents/surveillancereport/en/), 2014. Accessed 19 May 2014.
2. Tong SY, Chen LF, Fowler VG. Jr. Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance? Seminars in Immunopathology 2012; 34: 185-200.
3. Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nature Reviews Microbiology 2009; 7: 629-641.
4. Udo EE, Pearman JW, Grubb WB. Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. Journal of Hospital Infection 1993; 25: 97-108.
5. TongSY, et al.Community-associated strains of methicillin-resistant Staphylococcus aureus and methicillinsusceptible S. aureus in Indigenous northern Australia: epidemiology and outcomes. Journal of Infectious Diseases 2009; 199: 1461-1470.
6. Coombs GW, et al. Prevalence of MRSA strains among Staphylococcus aureus isolated from outpatients, 2006. Communicable Disease Intelligence 2009; 33: 10-20.
7. Bell SM, Gatus BJ, Pham JN. The Calibrated Dichotomous Sensitivity (CDS) test. Microbiology Australia 2000; 21: 23-24.
8. McMeniman E, et al. Skin disease in the first two years of life in Aboriginal children in East Arnhem Land. Australasian Journal of Dermatology 2011; 52: 270-273.
9. Tong SY, et al. Clinical correlates of Panton-Valentine leukocidin (PVL), PVL isoforms, and clonal complex in the Staphylococcus aureus population of Northern Australia. Journal of Infectious Diseases 2010; 202: 760-769.
10. Tong SY, et al. Global implications of the emergence of community-associated methicillin-resistant Staphylococcus aureus in Indigenous populations. Clinical Infectious Diseases 2008; 46: 1871-1878.
11. Stinear TP, et al. Adaptive change inferred from genomic population analysis of the ST93 epidemic clone of community-associated methicillin-resistant Staphylococcus aureus. Genome Biology and Evolution 2014; 6: 366-378.
12. Valery PC, et al. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial. Lancet Respiratory Medicine 2013; 1: 610-620.
13. Bowen AC, et al. Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial. Lancet. Published online: 27 August 2014. doi:10.1016/S0140-6736(14)60841-2.
14. Tong SY, Kearns AM. Community-associated MRSA from the Indian subcontinent. Lancet Infectious Diseases 2013; 13: 734-735.